Goday A, Motaña E, Ercilla G, Fernandez J, Gomis R, Vilardell E
Servei d'Endocrinologia i Diabetis, Hospital Clinic, Barcelona, Spain.
Acta Diabetol Lat. 1990 Jul-Sep;27(3):215-22. doi: 10.1007/BF02581333.
The HLA haplotype and its relationships with clinical, biological and immunological parameters were analyzed in a group of 87 Spanish type 1 diabetic patients at the clinical onset of the disease. The frequency of HLA-B18, DR3 and DR4 antigens was significantly increased whereas DR2, DR5 and DR7 were decreased in comparison with 189 healthy unrelated controls without family history of diabetes. DR3 showed a maximum relative risk for diabetes (5.5) whereas DR4 had a lower one (4.0). HLA-DR4 patients were younger at the time of diagnosis than DR4 negative (16.7 vs 21.4 years). We found no statistically significant relationship between HLA antigens and the other variables studied including the presence of islet cell antibodies, complement fixing islet cell antibodies, insulin autoantibodies, organ-specific antibodies, fasting and maximal glucagon stimulated C-peptide levels, initial glycemia and glycosylated hemoglobin.
在一组87例西班牙1型糖尿病患者疾病临床发病时,分析了HLA单倍型及其与临床、生物学和免疫学参数的关系。与189名无糖尿病家族史的健康无关对照相比,HLA - B18、DR3和DR4抗原的频率显著增加,而DR2、DR5和DR7则降低。DR3显示出最高的糖尿病相对风险(5.5),而DR4的相对风险较低(4.0)。HLA - DR4患者诊断时的年龄比DR4阴性患者年轻(16.7岁对21.4岁)。我们发现HLA抗原与其他研究变量之间无统计学显著关系,这些变量包括胰岛细胞抗体、补体结合胰岛细胞抗体、胰岛素自身抗体、器官特异性抗体、空腹和最大胰高血糖素刺激的C肽水平、初始血糖和糖化血红蛋白。